'Mapping'health state utility values from non-preference-based measures: a systematic literature review in rare diseases
M Meregaglia, A Whittal, E Nicod, M Drummond - Pharmacoeconomics, 2020 - Springer
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
'Mapping'Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.
M Meregaglia, A Whittal, E Nicod… - Pharmacoeconomics, 2020 - europepmc.org
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
'Mapping'Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases
M Meregaglia, A Whittal, E Nicod… - …, 2020 - econpapers.repec.org
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
[PDF][PDF] 'Mapping'health state utility values from non-preference based measures: a systematic literature review in rare diseases
M Meregaglia, A Whittal, E Nicod, M Drummond - core.ac.uk
Background: In rare disease (RD) studies, generic preference-based patient-reported
outcome measures (PROMs) that yield health state utility values (HSUVs) are seldom …
outcome measures (PROMs) that yield health state utility values (HSUVs) are seldom …
[引用][C] 'Mapping'Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases
M Meregaglia, A Whittal, E Nicod, M Drummond - PharmacoEconomics, 2020 - cir.nii.ac.jp
‘Mapping’ Health State Utility Values from Non-preference-Based Measures: A Systematic
Literature Review in Rare Diseases | CiNii Research CiNii 国立情報学研究所 学術情報 …
Literature Review in Rare Diseases | CiNii Research CiNii 国立情報学研究所 学術情報 …
'Mapping'health state utility values from non-preference-based measures: a systematic literature review in rare diseases
M Meregaglia, A Whittal, E Nicod… - …, 2020 - iris.unibocconi.it
Background: The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
'Mapping'Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases
M Meregaglia, A Whittal, E Nicod… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
[PDF][PDF] 'Mapping'health state utility values from non-preference based measures: a systematic literature review in rare diseases
M Meregaglia, A Whittal, E Nicod, M Drummond - pure.york.ac.uk
Background: In rare disease (RD) studies, generic preference-based patient-reported
outcome measures (PROMs) that yield health state utility values (HSUVs) are seldom …
outcome measures (PROMs) that yield health state utility values (HSUVs) are seldom …
'Mapping'Health State Utility Values from Non‑preference‑Based Measures: A Systematic Literature Review in Rare Diseases
M Meregaglia, A Whittal, E Nicod… - …, 2020 - search.proquest.com
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
'Mapping'Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases
M Meregaglia, A Whittal, E Nicod… - …, 2020 - ideas.repec.org
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …